-
Xylem appoints Andrea van der Berg CFO; Grogan departs Aug 31; reaffirms 2026 guidance
William K. Grogan resigns as EVP & CFO effective Aug 31, 2026, to pursue another opportunity; stays through Sep 13.
-
Xylem Q2 orders surge 42% to $3.1B; raises full-year adjusted EPS guidance to $5.55-$5.70
Revenue $2.3B (+2% reported, +1% organic); GAAP EPS $1.11 (+19%), adjusted EPS $1.46 (+16%).
-
Xylem Q1 adjusted EPS $1.12 (+9%), revenue $2.1B (+3%); FY guidance raised
Q1 orders $2.2B (+3% reported, flat organic); revenue $2.1B (+3% reported).
-
Xylem Board authorizes $1.5B share repurchase program with no expiration
New share repurchase program authorizes up to $1.5 billion in common stock purchases.
-
Xylem Q4 adjusted EPS $1.42 (+20% YoY), full-year revenue $9.0B record; dividend raised 8%
Q4 revenue $2.4B (+6% reported, +4% organic); orders $2.4B (+9%, +7% organic).
-
Xylem Q3 2025: revenue up 8% to $2.3B; adj. EPS $1.37, +23%; raises full-year guidance
Revenue $2.3B, +8% reported (+7% organic); net income $227M ($0.93 EPS).
-
Xylem Q2 revenue $2.3B (+6% organic); EPS $0.93; adj. EPS $1.26; raises FY guidance
Revenue $2.3B, up 6% reported and organic; net income $226M ($0.93/share), up 16%.
-
Xylem Q1 revenue $2.1B, adj EPS $1.03, beats expectations; reaffirms FY guidance
Revenue $2.1B, up 2% reported and 3% organic; book-to-bill ratio above 1.0.
-
Xylem beats Q4 guidance; revenue $2.3B, adj. EPS $1.18; raises dividend 11%
Q4 revenue $2.3B, up 7% organic; orders $2.2B, up 7%; GAAP EPS $1.34 (+22%), adjusted EPS $1.18 (+19%).
-
Xylem confirms FY2024 results in-line/above guidance; announces restructuring with $95-115M charges
On Jan 28, 2025, management committed to a restructuring plan with workforce reductions across all businesses.
-
Xylem Q3 revenue $2.1B, adjusted EPS $1.11 (+12% YoY); narrows FY guidance
Revenue $2.1B, up 1% reported and organic; orders up 8%.
-
Xylem appoints Meredith Emmerich as Applied Water President; Cerwinka steps down
Franz Cerwinka steps down as SVP & President, Applied Water effective Oct 21; advisor until March 31, 2025.
-
Xylem Q2 revenue $2.2B (+26% reported, +9% organic); EPS $0.80, adj EPS $1.09; raises FY guidance
Net income $194M ($0.80 EPS), up 78%; adjusted EPS $1.09, up 11%.
-
Xylem beats Q1 estimates, raises FY revenue and adjusted EPS guidance
Q1 revenue of $2.0B (+40% reported, +7% organic); orders $2.2B (+43% reported, +3% organic).
-
Xylem Q4 revenue $2.1B, +41%; FY23 adj. EPS $3.78, +20%; initiates FY24 guidance $4.00-4.20, dividend +9%
Q4 orders $2.0B (+42% reported, +10% organic); revenue $2.1B (+41% reported, +9% organic).
-
Xylem creates Water Solutions and Services segment effective Jan 1, 2024
New WSS segment unifies legacy Evoqua ISS with Xylem dewatering and assessment services.
-
Xylem Q3 revenue $2.1B (+50% reported, +10% organic); raises FY guidance
Revenue $2.1B, up 50% reported, 10% organic; orders up 43% reported, 3% organic.
-
Xylem appoints Matthew Pine as CEO effective Jan 1, 2024; William Grogan as CFO effective Oct 1, 2023
Patrick Decker retires as CEO effective Dec 31, 2023; will serve as senior advisor through March 31, 2024.
-
Xylem Q2 revenue up 26% to $1.7B, adjusted EPS $0.98; raises FY guidance
Revenue $1.7B, up 26% reported and 15% organic; net income $92M, GAAP EPS $0.45.
-
Xylem completes Evoqua acquisition; files Evoqua FY2022 financials: rev $1.74B, net $72.3M
Merger closed May 24, 2023; Evoqua historical financials filed in 8-K/A amendment.
-
Xylem Q2 revenue $1.7B (+26% reported, +15% organic); raises FY guidance
GAAP EPS $0.45 (down 27%); adjusted EPS $0.98 (up 32%).
-
Xylem completes $7.5B all-stock acquisition of Evoqua; forms world's largest pure-play water tech company
Each Evoqua share converted into 0.48 Xylem share; Xylem holders own ~75%, Evoqua ~25% fully diluted.
-
Xylem shareholders approve share issuance for Evoqua merger; closing awaits China clearance
Shareholders voted 145.6M FOR, 585K AGAINST, 1.4M abstentions on share issuance proposal.
-
Xylem Q1 revenue $1.4B (+14%), adj. EPS $0.72 (+53%); raises full-year guidance
Revenue $1.4B, up 14% reported and 17% organically; GAAP EPS $0.54, adjusted EPS $0.72.
-
Xylem Q4 revenue $1.5B (+14%), adj EPS $0.92 (+46%); guides FY23 adj EPS $3.00-$3.25
Q4 revenue $1.5B (+14% reported, +20% organic); adj EPS $0.92 (+46% vs prior year).
-
Xylem to acquire Evoqua in $7.5B all-stock deal; 0.48 exchange ratio, ~29% premium
Enterprise value ~$7.5B; Evoqua shareholders receive 0.48 Xylem shares per share, valued at ~$52.89, a 29% premium.
-
Xylem appoints Matthew Pine as COO effective Jan 1, 2023; drives operational excellence
Matthew Pine appointed COO effective Jan 1, 2023; will oversee all three business segments and regions.
-
Xylem to redeem entire €500M 2.250% Senior Notes due 2023 on Dec 12, 2022
Redemption of €500M aggregate outstanding principal amount of 2.250% Senior Notes due 2023.
-
Xylem Q3 revenue $1.4B, adj EPS $0.79; raises FY2022 revenue and EPS guidance
Q3 revenue $1.4B, +9% reported, +16% organic; net income $12M/$0.07 GAAP EPS due to pension settlement.
-
Xylem Q2 revenue $1.4B, EPS $0.62 (adj $0.66); raises FY organic revenue guidance to 8-10%
Revenue $1.4B, +1% reported (+6% organic); net income $112M ($0.62 EPS); adj EPS $0.66.
-
Xylem Q1 rev $1.3B, EPS $0.45; raises FY22 organic rev guide to 4-6%, adj EPS $2.40-2.70
Q1 revenue $1.3B, up 4% organically; organic orders +14%, record backlog.
-
Xylem reports FY2021 rev $5.2B (+7%), adj EPS $2.49 (+21%); guides FY22 adj EPS $2.35-$2.70
Q4 revenue $1.32B; Q4 adj EPS $0.63; FY net income $427M, adj net income $452M.
-
Xylem Q3 revenue $1.27B (+2% organic); cuts FY guidance on supply chain issues
Q3 reported EPS $0.63, adjusted EPS $0.63; revenue $1.27B (+4% reported, +2% organic).
-
Xylem Q2 revenue $1.35B (+16% reported); raises FY organic growth guidance to 6-8%
Net income $113M ($0.62 EPS); adjusted EPS $0.66; revenue up 11% organically vs prior year.